Details for 2017191362

Up to date per 01.04.2026

Actions

Title / Product Name

5-((HALOPHENYL)-3-HALO-PYRIDIN-2-YL)-NITRIL-DERIVATE ALS ZWISCHENPRODUKTE ZUR HERSTELLUNG VON [(5-(HALOPHENYL)-3-HYDROXYPYRIDIN-2-CARBONYL)-AMINO]ALKANSÄURE DERIVATE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017191362

EP Publication Number

3290404

E-Number

1212059

Language

PCT Number

Publication Date

07.03.2018 A

11.12.2019 B1

Registration Date

11.12.2019

AT Publication Date

15.12.2019

Application Date

05.06.2012

Registration Number

Priorities

06.06.2011

201161493536 P

IPC

C07D 213/81 20060101AFI20190531BHEP

Maximum Duration of Protection

05.06.2032

Owner

Akebia Therapeutics Inc.245 First Street, Suite 1100 Cambridge, MA 02142US

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

LANTHIER, Christopher, M.3326 Aberdeen Avenue Burlington, Ontario L7M 3YACA

GORIN, Boris2313 Grand Ravine Drive Oakville, Ontario L6H 6A8CA

OUDENES, Jan12 Woodsend Crescent Aurora, Ontario L4G 6W6CA

DIXON, Craig, Edward30 Corvinelli Drive Brooklin, Ontario L1M 0G7CA

LU, Alan, Qingbo5120 Oscar Peterson Blvd. Mississauga, Ontario L5M 7W4CA

COPP, James, Densmore1430 South Runyon Road Greenwood, IN Indiana 46143US

JANUSZ, John, Michael7385 Desert Springs Court West Chester, OH Ohio 45069US

Information about Fees